1-2 of 2
Kana Matsumoto, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Management of Adverse Events Associated with Dasatinib during Early Periods of Therapy in the Treatment of Chronic Myeloid Leukemia -a Clinical Report of Daria-01 Study

Shuichi Mizuta, MD, Hisashi Tsurumi, Masashi Sawa, MD PhD, Kana Matsumoto, PhD, Kotaro Miyao, MD, Takeshi Hara, MD PhD, Takeshi Takahashi, MD PhD, Reona Sakemura, MD, Akio Kohno, MD PhD, Mari Oba, Satoshi Morita, PhD, Junichi Sakamoto, MDPhD, Nobuhiko Emi, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4537.
https://doi.org/10.1182/blood.V124.21.4537.4537
Published: 2014
Journal Articles

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Naoyuki Uchida, MD, Michihiro Hidaka, MD, Toru Sakura, MD, Toshihiro Miyamoto, MD, PhD, Tomoaki Fujisaki, MD, PhD, Tetsuya Eto, MD, PhD, Yoshinobu Maeda, MD, PhD, Kenji Fukuno, MD, PhD, Kana Matsumoto, PhD, Kunihiko Morita, PhD, Junji Kishimoto, PhD, Takahiro Fukuda, MD, PhD, Takanori Teshima, MD, PhD, Shuichi Taniguchi, MD, PhD, Shin-Ichiro Mori, MD, Mine Harada, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3477.
https://doi.org/10.1182/blood.V116.21.3477.3477
Published: 2010